MML Investors Services’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$869K Sell
8,744
-3,190
-27% -$416K ﹤0.01% 1869
2025
Q4
$1.45M Buy
11,934
+419
+4% +$52.6K ﹤0.01% 1572
2025
Q3
$1.29M Buy
11,515
+2,917
+34% +$341K ﹤0.01% 1556
2025
Q2
$1.15M Buy
8,598
+1,792
+26% +$197K ﹤0.01% 1577
2025
Q1
$458K Buy
6,806
+563
+9% +$38.7K ﹤0.01% 2038
2024
Q4
$389K Buy
6,243
+2,120
+51% +$197K ﹤0.01% 2094
2024
Q3
$647K Buy
4,123
+2,407
+140% +$371K ﹤0.01% 1708
2024
Q2
$258K Buy
+1,716
New +$206K ﹤0.01% 2186

Other funds holding TMDX

MML Investors Services's TMDX Position: Q1 2026 in Review

MML Investors Services reduced its Transmedics (TMDX) stake by 27% in Q1 2026, selling an estimated $416K and leaving 8,744 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

MML Investors Services first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.45M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • MML Investors Services held 8,744 shares of Transmedics worth $869K as of Q1 2026.
  • MML Investors Services sold 3,190 Transmedics shares in Q1 2026, an estimated $416K.
  • Transmedics made up ﹤0.01% of MML Investors Services's portfolio in Q1 2026, its #1869 holding.
  • MML Investors Services first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • MML Investors Services's Transmedics position peaked at $1.45M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.